Page 481 - Read Online
P. 481

Campobasso et al. Mini-invasive Surg 2021;5:45  https://dx.doi.org/10.20517/2574-1225.2021.92  Page 9 of 9

               7.       Cindolo L, Ruggera L, Destefanis P, Dadone C, Ferrari G. Vaporize, anatomically vaporize or enucleate the prostate? Int Urol Nephrol
                   2017;49:405-11.  DOI  PubMed
               8.       Law KW, Tholomier C, Nguyen DD, et al. Global Greenlight Group: largest international Greenlight experience for benign prostatic
                   hyperplasia to assess efficacy and safety. World J Urol 2021.  DOI  PubMed
               9.       Meskawi M, Hueber PA, Valdivieso R, et al. Complications and functional outcomes of high-risk patient with cardiovascular disease
                   on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate
                   hyperplasia. World J Urol 2019;37:1671-8.  DOI  PubMed
               10.      Campobasso D, Marchioni M, Altieri V, et al. GreenLight photoselective vaporization of the prostate: one laser for different prostate
                   sizes. J Endourol 2020;34:54-62.  DOI  PubMed
               11.      Leonardo C, Lombardo R, Cindolo L, et al; AGILE Group. What is the standard surgical approach to large volume BPE? Minerva
                   Urol Nefrol 2020;72:22-9.  DOI  PubMed
               12.      De Nunzio C, Lombardo R, Autorino R, et al. Contemporary monopolar and bipolar transurethral resection of the prostate: prospective
                   assessment of complications using the Clavien system. Int Urol Nephrol 2013;45:951-9.  DOI  PubMed
               13.      Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F. The modified Clavien classification system: a standardized platform
                   for reporting complications in transurethral resection of the prostate. World J Urol 2011;29:205-10.  DOI  PubMed  PMC
               14.      Hossack T, Woo H. Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy.
                   Prostate Int 2014;2:182-7.  DOI  PubMed  PMC
               15.      Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing greenlight-XPS laser vaporization of
                   the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the
                   GOLIATH study. Eur Urol 2016;69:94-102.  DOI  PubMed
               16.      Ajib K, Mansour M, Zanaty M, et al. Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: five-year
                   experience of safety, efficiency, and functional outcomes. Can Urol Assoc J 2018;12:E318-24.  DOI  PubMed  PMC
               17.      Cindolo L, De Nunzio C, Greco F, et al; Members of Green Laser Italian Group. Standard vs. anatomical 180-W GreenLight laser
                   photoselective vaporization of the prostate: a propensity score analysis. World J Urol 2018;36:91-7.  DOI  PubMed
               18.      Campobasso D, Acampora A, De Nunzio C, et al. Post-operative acute urinary retention after greenlight laser. Analysis of risk factors
                   from a multicentric database. Urol J 2021.  DOI  PubMed
               19.      Laine-Caroff P, Pradere B, Ruffion A, Bruyere F. Greenlight laser photoselective vaporization vs open simple prostatectomy: long-
                   term functional outcomes after treatment of large volume prostates (> 80 cc). Int Urol Nephrol 2021;53:1289-95.  DOI  PubMed
               20.      Meskawi M, Hueber PA, Valdivieso R, et al. Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight
                   XPS in men with large prostates (prostate volume > 100 cc). World J Urol 2017;35:1603-9.  DOI  PubMed
               21.      Valdivieso R, Hueber PA, Meskawi M, et al. Multicentre international experience of 532-nm laser photoselective vaporization with
                   GreenLight XPS in men with very large prostates. BJU Int 2018;122:873-8.  DOI  PubMed
               22.      Stone BV, Chughtai B, Forde JC, Tam AW, Lewicki P, Te AE. Safety and efficacy of GreenLight XPS laser vapoenucleation in
                   prostates measuring over 150 mL. J Endourol 2016;30:906-12.  DOI  PubMed
               23.      Hueber PA, Bienz MN, Valdivieso R, et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180
                   Watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 2015;194:462-9.  DOI  PubMed
               24.      Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S. 180-W XPS GreenLight laser vaporization for benign prostate
                   hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 2015;30:317-23.  DOI  PubMed
               25.      Kim A, Hak AJ, Choi WS, Paick SH, Kim HG, Park H. Comparison of long-term effect and complications between holmium laser
                   enucleation and transurethral resection of prostate: nations-wide health insurance study. Urology 2021;154:300-7.  DOI  PubMed
               26.      Elshal AM, Soltan M, El-Tabey NA, Laymon M, Nabeeh A. Randomised trial of bipolar resection vs holmium laser enucleation vs
                   Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU Int
                   2020;126:731-8.  DOI  PubMed
               27.      Ferrari G, Rabito S, Gatti L, et al. Green Light laser enucleation of the prostate with early apical release is safe and effective: single
                   center experience and revision of the literature. Minerva Urol Nephrol 2021.  DOI  PubMed
   476   477   478   479   480   481   482   483   484   485   486